中药治疗IgA肾病的作用与机制综述
本文综述1990至2022年PubMed等数据库中有关中药及活性成分治疗IgA肾病的临床试验、系统评价和Meta分析,发现中药活性成分常作用于多条信号通路,主要发挥抗氧化、抗炎、抗纤维化及调节自噬作用。结论认为中药通过辨证论治可多靶点治疗IgA肾病,疗效良好,可作为首选或替代疗法。
要点
- 中药活性成分通过抗氧化、抗炎、抗纤维化及调节自噬多靶点治疗IgA肾病。
- 中药辨证论治可作为IgA肾病的首选或替代疗法。
- 本综述为中药治疗IgA肾病提供了证据和研究方向。
核心结论
- 中药通过辨证论治从抗炎、抗氧化、抗纤维化和自噬方面多靶点治疗IgA肾病,疗效良好,可作为首选或替代疗法。
研究设计与样本
- 本综述检索PubMed、ResearchGate、Science Direct、Web of Science、中国知网和万方数据库中1990至2022年文献,关键词包括IgA肾病、中医、中药、机制、Meta分析、系统评价、RCT等。
主要发现
- 中药活性成分在IgA肾病临床治疗中常作用于多条信号通路,主要具有抗氧化、抗炎、抗纤维化和调节自噬作用。
临床怎么用
- 临床上可基于辨证论治使用中药作为IgA肾病的首选或替代疗法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immunoglobulin A nephropathy (IgAN), is the main cause of end-stage renal disease, that causes serious physical and psychological burden to patients worldwide. Some traditional treatment measures, such as blocking the renin-angiotensin-aldosterone system, controlling blood pressure, and following a low-protein diet, may not achieve satisfactory results. Therefore, more effective and safe therapies for IgAN are urgently needed. PURPOSE: The aim of this review is to summarize the clinical efficacy of Chinese herbal medicines (CHMs) and their active ingredients in the treatment and management of IgAN based on the results of clinical trials, systematic reviews, and meta-analyses, to fully understand the advantages and perspectives of CHMs in the treatment of IgAN. STUDY DESIGN AND METHODS: For this review, the following electronic databases were consulted: PubMed, ResearchGate, Science Direct, Web of Science, Chinese National Knowledge Infrastructure and Wanfang Data, "IgA nephropathy," "traditional Chinese medicine," "Chinese herbal medicine," "herb," "mechanism," "Meta-analysis," "systematic review," "RCT" and their combinations were the keywords to search the relevant literature. Data were collected from 1990 to 2022. RESULTS: This review found that the active ingredients of CHMs commonly act on multiple signaling pathways in the clinical treatment of IgAN, mainly with antioxidant, anti-inflammatory and anti-fibrosis effects, and regulation of autophagy. CONCLUSION: Compared with the single-target therapy of modern medicine, CHMs can regulate the corresponding pathways from the aspects of anti-inflammation, anti-oxidation, anti-fibrosis and autophagy to play a multi-target treatment of IgAN through syndrome differentiation and treatment, which has good clinical efficacy and can be used as the first choice or alternative therapy for IgAN treatment. This review provides evidence and research direction for a comprehensive clinical understanding of the protective effect of Chinese herbal medicine on IgAN.
引用
- Ma S, Zhao M, Chang M, et al. Effects and mechanisms of Chinese herbal medicine on IgA nephropathy. Phytomedicine. 2023. PMID: 37307737. doi:10.1016/j.phymed.2023.154913
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。